Farallon Capital Partners, L.P. 13D and 13G filings for BridgeBio Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-29 4:48 pm Purchase | 2026-05-22 | 13G | BRIDGEBIO PHARMA INC BBIO | Farallon Capital Partners, L.P. | 10,226,063 5.200% | 10,226,063 (New Position) | Filing |